Programmed Death-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Expression in Aggressive Pediatric Lymphomas

被引：0
|
作者：
Coffey, Amy M.
Curry, Jonathan L.
Marcogliese, Andrea N.
Tetzlaff, Michael T.
Kamdar, Kala
Elghetany, Mohamed T.
Curry, Choladda V.
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Texas Childrens Hosp, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1379
引用
收藏
页码：344A / 344A
页数：1
相关论文
共 50 条
  • [21] Prognostic Impact of Programmed Cell Death-1 (PD-1) and PD-Ligand 1 (PD-L1) Expression in Thymic Cancer
    Funaki, S.
    Shintani, Y.
    Ose, N.
    Kawamura, T.
    Kanzaki, R.
    Minami, M.
    Okumura, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2064 - S2065
  • [22] Programmed Death Ligand 1 (PD-L1) Expression in Lymphomas: State of the Art
    Zanelli, Magda
    Fragliasso, Valentina
    Parente, Paola
    Bisagni, Alessandra
    Sanguedolce, Francesca
    Zizzo, Maurizio
    Broggi, Giuseppe
    Ricci, Stefano
    Palicelli, Andrea
    Foroni, Moira
    Gozzi, Fabrizio
    Gentile, Pietro
    Morini, Andrea
    Koufopoulos, Nektarios
    Caltabiano, Rosario
    Cimino, Luca
    Fabozzi, Massimiliano
    Cavazza, Alberto
    Neri, Antonino
    Ascani, Stefano
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
  • [23] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Neelima Vidula
    Christina Yau
    Hope S. Rugo
    [J]. Breast Cancer Research and Treatment, 2021, 187 : 387 - 395
  • [24] Association Between Activation of the Programmed Cell Death-1 (PD-1)/Programmod Death-Ligand 1 (PD-L1) Pathway and Pain in Patients with Cancer
    Zhang, Jian
    Zhang, Huali
    Luo, Yongli
    [J]. MEDICAL SCIENCE MONITOR, 2019, 25 : 1275 - 1282
  • [25] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Vidula, Neelima
    Yau, Christina
    Rugo, Hope S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (02) : 387 - 395
  • [26] Programmed Death-Ligand 1 (PD-L1) Expression in Pheochromocytoma: Clinicopathologic Correlation
    Xiong, Meng-Jun
    Kissick, Haydn
    Master, Viraj
    Osunkoya, Adeboye O.
    [J]. LABORATORY INVESTIGATION, 2019, 99
  • [27] Programmed Death-ligand 1 (PD-L1) Expression in Thymic Epithelial Tumors
    Bedekovics, Judit
    Beke, Livia
    Mokanszki, Attila
    Szilagyi, Szabolcs
    Mehes, Gabor
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (01) : 1 - 9
  • [28] Programmed Death-Ligand 1 (PD-L1) Expression in Pheochromocytoma: Clinicopathologic Correlation
    Xiong, Meng-Jun
    Kissick, Haydn
    Master, Viraj
    Osunkoya, Adeboye O.
    [J]. MODERN PATHOLOGY, 2019, 32
  • [29] Programmed Cell Death-Ligand 1 (PD-L1) Expression in Anal Cancer
    Govindarajan, Rangaswamy
    Gujja, Swetha
    Siegel, Eric R.
    Batra, Anu
    Saeed, Anwaar
    Lai, Keith
    James, Jennifer D.
    Fogel, Bradley J.
    Williamson, Stephen
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (07): : 638 - 642
  • [30] Programmed death-ligand 1 (PD-L1) expression in pleomorphic carcinoma of the lung
    Imanishi, Naoko
    Hirai, Ayako
    Yoneda, Kazue
    Shimajiri, Shohei
    Kuwata, Taiji
    Tashima, Yuko
    Takeuchi, Masahiro
    Iwai, Yoshiko
    Ichiki, Yoshinobu
    Tanaka, Fumihiro
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (07) : 1563 - 1569
12345